Related Experiment Video
Updated: Jul 16, 2026
08:56
Kinetic Measurement and Real Time Visualization of Somatic Reprogramming
Published on: July 30, 2016
Stem cell repopulation efficiency but not pool size is governed by p27(kip1)
T Cheng1, N Rodrigues, D Dombkowski
1Massachusetts General Hospital AIDS Research Center, Harvard Medical School, 149 13th Street, Room 5212 Boston, Massachusetts 02129, USA. cheng-tao@mgh.harvard.edu
Nature Medicine
|November 4, 2000
Summary
The cyclin-dependent kinase inhibitor p27 (p27) regulates progenitor cells, not stem cells. Modulating p27 in stem cells could enhance gene therapy for blood cell production.
Area of Science:
- Hematopoiesis
- Cell Cycle Regulation
- Stem Cell Biology
Background:
- Sustained blood cell production relies on quiescent stem cells and their progenitors.
- Cyclin-dependent kinase inhibitors (CDKIs) like p21 play a key role in stem cell regulation.
- The specific roles of different CDKIs in distinct hematopoietic cell populations are not fully understood.
Purpose of the Study:
- To investigate the role of the CDKI p27(kip1) (p27) in regulating hematopoietic stem and progenitor cells.
- To determine if p27 has distinct functions compared to p21 in governing stem and progenitor cell populations.
- To explore the potential of modulating p27 for stem cell gene therapy.
Main Methods:
- Competitive transplantation assays using p27-deficient stem cells.
- Analysis of stem cell number, cell cycling, and self-renewal.
- Assessment of progenitor proliferation and pool size dynamics.
Main Results:
- p27 deficiency did not impact stem cell number, cell cycling, or self-renewal.
- p27 significantly altered progenitor cell proliferation and pool size.
- p27-deficient stem cells generated progenitors that ultimately dominated blood cell production upon competitive transplantation.
- Distinct CDKIs, p21 and p27, govern separate stem and progenitor cell populations.
Conclusions:
- p27 plays a critical, distinct role in regulating hematopoietic progenitor cells, separate from p21's role in stem cells.
- Modulating p27 expression in stem cells can profoundly influence downstream progenitor populations and overall blood cell output.
- Targeting p27 offers a potential strategy for enhancing the efficacy of stem cell gene therapy by amplifying the impact of transduced cells.
More Related Videos
09:45Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors
Published on: January 1, 2017
07:01Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
Published on: May 2, 2025
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
02:36Cells Coordinate Growth and Proliferation
Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:14Maintenance of the ES Cell State
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...